​Stem Cell Therapy in the Philippines: What Does the Science Actually Say?

​Stem Cell Therapy in the Philippines: What Does the Science Actually Say?

Understanding Mesenchymal Stem Cells, Regenerative Medicine, and the Evidence Behind an Emerging Field

By Dr. Daryl Joel Dumdum, MD, DFM, FSRM

When patients first come to me asking about stem cell therapy, the questions are often remarkably similar:

“Doc, do stem cells really work?”

“Can stem cells repair damaged organs?”

“Is stem cell therapy already available in the Philippines?”

And perhaps the most important question:

“Is there actual scientific evidence behind it?”

My answer begins with an important distinction.

Stem cell science is real.

Regenerative medicine is real.

But not every treatment being promoted as “stem cell therapy” has been proven to work for every disease.

That distinction is extremely important.

As physicians working in this rapidly developing field, our responsibility is not to sell hope without evidence. Our responsibility is to understand the science, follow the research, properly select patients, discuss uncertainty, monitor outcomes, and continuously evaluate whether emerging therapies are genuinely helping the people we treat.

What Exactly Are Stem Cells?

Stem cells are unique because they possess two important biological characteristics.

First, they can self-renew, meaning they can produce additional stem cells.

Second, under appropriate biological conditions, certain stem cells or their progeny can develop into more specialized cell types.

However, the term “stem cell” covers several very different biological entities.

These include:

• embryonic stem cells
• induced pluripotent stem cells
• hematopoietic stem cells
• tissue-specific stem/progenitor cells
• mesenchymal stromal/stem cells, commonly called MSCs

For regenerative medicine, mesenchymal stromal cells (MSCs) have attracted enormous scientific interest.

They can be obtained or developed from several tissue sources, including bone marrow, adipose tissue and perinatal tissues such as the umbilical cord.

But the modern understanding of MSCs is more sophisticated than simply saying that they “turn into new organs.”

How Do MSCs Potentially Work?

One of the most fascinating developments in regenerative medicine is our evolving understanding of how MSCs may exert biological effects.

Earlier concepts focused heavily on the idea that infused stem cells would travel to damaged tissue, permanently engraft, and directly replace injured cells.

Today, researchers increasingly recognize another major mechanism:

Paracrine signaling.

MSCs can release biologically active molecules into their surrounding environment.

These signals may influence:

• inflammation
• immune activity
• angiogenesis
• tissue repair pathways
• cell survival
• communication between cells

This secretory activity also helps explain the increasing scientific interest in the MSC secretome and extracellular vesicles, including exosomes.

In other words, regenerative medicine is becoming less about the simplistic idea of “injecting new cells to replace old cells” and more about understanding how cells communicate with and influence the body’s biological environment.

Immunomodulation: One of the Most Important Areas of MSC Research

MSCs are also being investigated for their ability to interact with the immune system.

They appear capable of influencing several components of immune activity.

This is one reason researchers continue investigating MSC-based interventions in inflammatory and immune-mediated diseases.

But biological plausibility is not the same as proven clinical effectiveness.

A therapy can demonstrate fascinating effects in the laboratory and still fail to produce meaningful benefits in humans.

That is precisely why properly designed clinical trials are essential.

What Diseases Are Scientists Studying?

Stem cell and MSC research now covers a remarkably broad range of medical conditions.

Clinical and translational research has investigated potential applications involving areas such as:

• musculoskeletal disorders
• cardiovascular disease
• neurological conditions
• inflammatory diseases
• immune-mediated disorders
• tissue injury and wound healing

Research is also continuing in areas such as stroke recovery, osteoarthritis and other degenerative conditions.

The quality and maturity of the evidence, however, varies substantially between indications.

Some applications of stem-cell biology are already established medical practice — particularly certain hematopoietic stem-cell transplantation procedures for blood and immune disorders.

Many other uses of MSCs and related regenerative products remain investigational or have not yet accumulated enough high-quality evidence to be considered standard treatment.

That distinction should always be explained to patients.

What Does the Scientific Community Say?

The International Society for Stem Cell Research (ISSCR), one of the major international scientific organizations in the field, emphasizes that potential stem-cell interventions should progress through rigorous preclinical investigation and appropriately designed clinical trials.

The organization stresses the importance of demonstrating quality, safety and clinically meaningful effectiveness before novel interventions become routine clinical care.

This is an important principle.

Excitement should never move faster than evidence.

Safety Is More Than Asking, “Did the Patient Have a Reaction?”

When people discuss the safety of stem cell therapy, they sometimes focus only on what happens during or immediately after an infusion.

But evaluating cellular therapy requires a much broader perspective.

Physicians and researchers must consider factors such as:

• source of the cells
• donor screening
• manufacturing standards
• sterility
• cellular identity and characterization
• viability
• contamination risk
• route of administration
• dose
• patient selection
• short-term adverse events
• long-term monitoring

The biological product itself matters enormously.

Two products both described as “stem cells” may not necessarily be equivalent.

This is why manufacturing quality, laboratory standards and traceability are fundamental components of responsible regenerative medicine.

Why Patients Must Be Careful About Extraordinary Claims

The growing popularity of regenerative medicine has unfortunately also created an environment where patients may encounter exaggerated promises.

Claims that a single stem cell product can reliably cure dozens of unrelated diseases should immediately raise questions.

Medicine rarely works that way.

Different diseases have different biological mechanisms.

Different patients have different risks.

Different cell products may behave differently.

And different routes and doses may produce different outcomes.

Patients should be particularly cautious when they encounter phrases such as:

“Guaranteed cure.”

“Works for everyone.”

“No risks.”

“Can reverse any disease.”

These statements are inconsistent with responsible scientific medicine.

The U.S. FDA, for example, has repeatedly warned consumers about unapproved regenerative medicine products marketed with unsupported claims. The FDA also notes that, in the United States, approved stem-cell products are primarily blood-forming stem cells used for disorders of the hematopoietic system.

Regulatory frameworks differ between countries, so patients in the Philippines should discuss the regulatory status, evidence, manufacturing standards and intended use of any proposed cellular product with qualified healthcare professionals.

What Should Patients Ask Before Considering Stem Cell Therapy?

Patients considering regenerative medicine should become active participants in the decision-making process.

Some important questions include:

What exactly is the cellular product being proposed?

Where were the cells obtained?

How were they processed and manufactured?

What quality-control testing was performed?

What evidence exists for my particular medical condition?

Is this treatment established, investigational, or being offered under another appropriate clinical pathway?

What are the known and unknown risks?

What conventional treatments remain available to me?

How will my outcomes be objectively measured?

What follow-up will occur after treatment?

A responsible regenerative medicine consultation should welcome these questions.

Regenerative Medicine Should Not Replace Good Medicine

This is one principle I strongly believe in.

Regenerative medicine should not exist in isolation from conventional medical care.

A patient with diabetes still requires proper metabolic management.

A patient recovering from stroke still needs appropriate neurological care and rehabilitation.

A patient with osteoarthritis still requires proper diagnosis, physical therapy, weight management when appropriate, and evidence-based musculoskeletal treatment.

A patient with cardiovascular disease still needs appropriate cardiovascular risk management.

Emerging regenerative strategies should therefore be considered within a comprehensive medical plan, not as an excuse to abandon proven therapy.

Stem Cell Therapy in Davao and the Philippines

Interest in stem cell therapy in the Philippines has increased considerably as patients become more aware of regenerative medicine.

In Davao and throughout Mindanao, I have also seen increasing interest from patients who previously believed they needed to travel internationally simply to explore advanced regenerative medicine.

That creates both an opportunity and a responsibility.

If regenerative medicine is going to continue developing in the Philippines, it must develop with:

Science.

Ethics.

Transparency.

Proper patient selection.

Quality manufacturing.

Objective outcome monitoring.

Research and publication.

The goal should never be simply to make stem cell therapy more available.

The goal should be to make regenerative medicine more responsible, measurable and evidence-informed.

From Treatment to Research

One of the most important developments I would like to see in Philippine regenerative medicine is a stronger culture of research.

Clinical experiences should not simply disappear after treatment.

When ethically and appropriately conducted, outcomes should be systematically documented.

Safety data should be collected.

Validated outcome measures should be used.

Interesting cases should become case reports.

Patient cohorts should eventually contribute to prospective research.

And where possible, Filipino physicians and scientists should contribute their own data to the international scientific literature.

The Philippines should not merely consume regenerative medicine technology.

We should help produce regenerative medicine science.

My Perspective as a Physician

As a Family Medicine physician and Fellow in Stem Cell and Regenerative Medicine, I find this field extraordinarily exciting.

But excitement must always be balanced by scientific discipline.

I believe regenerative medicine has the potential to become an increasingly important part of future healthcare.

I also believe physicians practicing in this field carry a special responsibility.

We must be willing to tell patients when the evidence is promising.

We must also be willing to tell them when the evidence remains uncertain.

Because ultimately, the credibility of regenerative medicine will not be built through extraordinary claims.

It will be built through good science, ethical practice, transparent outcomes and responsible physicians.

The Science of Hope

There is nothing wrong with giving patients hope.

Medicine has always carried hope.

But the strongest form of hope is not based on promises.

It is based on science.

Stem cell research is advancing rapidly. MSCs, extracellular vesicles, immune-cell therapies, tissue engineering, gene technologies and precision medicine are creating possibilities that would have seemed unimaginable only decades ago.

Some will ultimately transform medicine.

Others may not survive rigorous clinical testing.

Our responsibility is to discover the difference.

That is the future of responsible regenerative medicine in the Philippines.

Science before hype. Evidence before promises. Patient safety above everything.

About the Author

Dr. Daryl Joel Dumdum, MD, DFM, FSRM is a Diplomate in Family Medicine and Fellow in Stem Cell and Regenerative Medicine. He is the CEO of SH360 Medical Corporation and practices regenerative, preventive and precision healthcare in the Philippines, with Davao City serving as the organization’s main center.

His professional interests include mesenchymal stem cells, regenerative medicine, cellular therapies, precision healthcare, medical research and healthcare innovation.

References

International Society for Stem Cell Research. Guidelines for Stem Cell Research and Clinical Translation. 2025.

International Society for Stem Cell Research. Clinical Translation of Stem Cell-Based Interventions.

U.S. Food and Drug Administration. Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes.

Medical Disclaimer: This article is intended for educational purposes and does not constitute individual medical advice. The regulatory status and level of evidence for cell-based interventions vary according to the product, indication and jurisdiction. Patients should undergo appropriate medical evaluation and informed consent before considering investigational or emerging therapies.